Literature DB >> 33624374

Complete Biosynthetic Pathway of Alazopeptin, a Tripeptide Consisting of Two Molecules of 6-Diazo-5-oxo-l-norleucine and One Molecule of Alanine.

Seiji Kawai1, Yuko Sugaya1, Ryota Hagihara1, Hiroya Tomita1, Yohei Katsuyama1,2, Yasuo Ohnishi1,2.   

Abstract

DON (6-diazo-5-oxo-l-norleucine), a diazo-containing amino acid, has been studied for more than 60 years as a potent antitumor agent, but its biosynthesis has not been elucidated. Here we reveal the complete biosynthetic pathway of alazopeptin, the tripeptide Ala-DON-DON, which has antitumor activity, by gene inactivation and in vitro analysis of recombinant enzymes. We also established heterologous production of N-acetyl-DON in Streptomyces albus. DON is synthesized from lysine by three enzymes and converted to alazopeptin by five enzymes and one carrier protein. Most interestingly, transmembrane protein AzpL was indicated to catalyze diazotization using 5-oxolysine and nitrous acid as substrates. Site-directed mutagenesis of AzpL indicated that the hydroxy group of Tyr-93 is important for the diazotization. These findings expand our knowledge of the enzymology of N-N bond formation.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  N-N bonds; biosynthesis; diazo compounds; peptides; secondary metabolism

Year:  2021        PMID: 33624374     DOI: 10.1002/anie.202100462

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  2 in total

1.  Biosynthesis of triacsin featuring an N-hydroxytriazene pharmacophore.

Authors:  Antonio Del Rio Flores; Frederick F Twigg; Yongle Du; Wenlong Cai; Daniel Q Aguirre; Michio Sato; Moriel J Dror; Maanasa Narayanamoorthy; Jiaxin Geng; Nicholas A Zill; Rui Zhai; Wenjun Zhang
Journal:  Nat Chem Biol       Date:  2021-11-01       Impact factor: 16.174

2.  Molecular basis of enzymatic nitrogen-nitrogen formation by a family of zinc-binding cupin enzymes.

Authors:  Guiyun Zhao; Wei Peng; Kaihui Song; Jingkun Shi; Xingyu Lu; Binju Wang; Yi-Ling Du
Journal:  Nat Commun       Date:  2021-12-10       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.